Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis
ConclusionsThis case suggests that the individual use of a combination of rituximab and infliximab may be a promising strategy for the treatment in the long term of refractory orbital GPA.
Source: Autoimmunity Highlights - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Autoimmune Disease | Methotrexate | Remicade | Rituxan | Vasculitis